| Product Code: ETC6662806 | Publication Date: Sep 2024 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Shubham Padhi | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Canada Opiods Drug Market Overview |
3.1 Canada Country Macro Economic Indicators |
3.2 Canada Opiods Drug Market Revenues & Volume, 2021 & 2031F |
3.3 Canada Opiods Drug Market - Industry Life Cycle |
3.4 Canada Opiods Drug Market - Porter's Five Forces |
3.5 Canada Opiods Drug Market Revenues & Volume Share, By Product Type, 2021 & 2031F |
3.6 Canada Opiods Drug Market Revenues & Volume Share, By Application, 2021 & 2031F |
3.7 Canada Opiods Drug Market Revenues & Volume Share, By Distribution Channel, 2021 & 2031F |
4 Canada Opiods Drug Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of chronic pain conditions in Canada |
4.2.2 Growing geriatric population requiring pain management |
4.2.3 Rise in opioid prescriptions by healthcare providers |
4.3 Market Restraints |
4.3.1 Stringent regulations and policies surrounding opioid prescribing and use |
4.3.2 Public health concerns and awareness about opioid addiction and overdose |
4.3.3 Shift towards non-opioid alternatives for pain management |
5 Canada Opiods Drug Market Trends |
6 Canada Opiods Drug Market, By Types |
6.1 Canada Opiods Drug Market, By Product Type |
6.1.1 Overview and Analysis |
6.1.2 Canada Opiods Drug Market Revenues & Volume, By Product Type, 2021- 2031F |
6.1.3 Canada Opiods Drug Market Revenues & Volume, By Buprenorphine, 2021- 2031F |
6.1.4 Canada Opiods Drug Market Revenues & Volume, By Fentanyl, 2021- 2031F |
6.1.5 Canada Opiods Drug Market Revenues & Volume, By Hydrocodone, 2021- 2031F |
6.1.6 Canada Opiods Drug Market Revenues & Volume, By Morphine, 2021- 2031F |
6.1.7 Canada Opiods Drug Market Revenues & Volume, By Oxycodone, 2021- 2031F |
6.1.8 Canada Opiods Drug Market Revenues & Volume, By Tramadol, 2021- 2031F |
6.2 Canada Opiods Drug Market, By Application |
6.2.1 Overview and Analysis |
6.2.2 Canada Opiods Drug Market Revenues & Volume, By Pain Relief, 2021- 2031F |
6.2.3 Canada Opiods Drug Market Revenues & Volume, By Anesthesia, 2021- 2031F |
6.2.4 Canada Opiods Drug Market Revenues & Volume, By Cough Suppression, 2021- 2031F |
6.2.5 Canada Opiods Drug Market Revenues & Volume, By Diarrhea Suppression, 2021- 2031F |
6.2.6 Canada Opiods Drug Market Revenues & Volume, By Deaddiction, 2021- 2031F |
6.3 Canada Opiods Drug Market, By Distribution Channel |
6.3.1 Overview and Analysis |
6.3.2 Canada Opiods Drug Market Revenues & Volume, By Hospital Pharmacies, 2021- 2031F |
6.3.3 Canada Opiods Drug Market Revenues & Volume, By Retail Pharmacies, 2021- 2031F |
6.3.4 Canada Opiods Drug Market Revenues & Volume, By Drug Stores, 2021- 2031F |
6.3.5 Canada Opiods Drug Market Revenues & Volume, By Clinics, 2021- 2031F |
6.3.6 Canada Opiods Drug Market Revenues & Volume, By Others, 2021- 2031F |
7 Canada Opiods Drug Market Import-Export Trade Statistics |
7.1 Canada Opiods Drug Market Export to Major Countries |
7.2 Canada Opiods Drug Market Imports from Major Countries |
8 Canada Opiods Drug Market Key Performance Indicators |
8.1 Number of opioid prescriptions issued annually |
8.2 Percentage of healthcare providers using non-opioid pain management strategies |
8.3 Rate of opioid-related hospital admissions or overdose cases |
8.4 Amount of government funding allocated to opioid addiction treatment and prevention programs |
8.5 Patient satisfaction with pain management options provided |
9 Canada Opiods Drug Market - Opportunity Assessment |
9.1 Canada Opiods Drug Market Opportunity Assessment, By Product Type, 2021 & 2031F |
9.2 Canada Opiods Drug Market Opportunity Assessment, By Application, 2021 & 2031F |
9.3 Canada Opiods Drug Market Opportunity Assessment, By Distribution Channel, 2021 & 2031F |
10 Canada Opiods Drug Market - Competitive Landscape |
10.1 Canada Opiods Drug Market Revenue Share, By Companies, 2024 |
10.2 Canada Opiods Drug Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here